Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Browse by All Cardiff Authors

[up] Up a level
Number of items: 38.

Tallantyre, Emma C., Scurr, Martin J., Vickaryous, Nicola, Richards, Aidan, Anderson, Valerie, Baker, David, Chance, Randy, Evangelou, Nikos, George, Katila, Giovannoni, Gavin, Harding, Katharine E., Hibbert, Aimee, Ingram, Gillian, Jolles, Stephen, Jones, Meleri, Kang, Angray S., Loveless, Samantha, Moat, Stuart J., Robertson, Neil P., Rios, Francesca, Schmierer, Klaus, Willis, Mark, Godkin, Andrew and Dobson, Ruth 2022. Response to COVID-19 booster vaccinations in seronegative people with multiple sclerosis. Multiple Sclerosis and Related Disorders 64 , 103937. 10.1016/j.msard.2022.103937
file

Cauchi, Marija, Willis, Mark, Andrews, Angela, Backx, Matthijs, Brownlee, Wallace, Ford, Helen, Gran, Bruno, Jolles, Stephen, Price, Sian, Rashid, Waqar, Schmeirer, Klaus and Tallantyre, Emma 2022. Multiple Sclerosis and the risk of infection: Association of British Neurologists consensus guideline. Practical Neurology 10.1136/practneurol-2022-003370
file

Tallantyre, Emma, Vickaryous, Nicola, Anderson, Valerie, Asardag, Aliye Nazli, Baker, David, Bestwick, Jonathan, Bramhall, Kath, Chance, Randy, Evangelou, Nikos, George, Katila, Giovannoni, Gavin, Godkin, Andrew, Grant, Leanne, Harding, Katherine E, Hibbert, Aimee, Ingram, Gillian, Jones, Meleri, Kang, Angray S, Loveless, Samantha, Moat, Stuart J, Robertson, Neil, Schmierer, Klaus, Scurr, Martin, Shah, Sita Navin, Simmons, Jessica, Upcott, Matthew, Willis, Mark, Jolles, Stephen and Dobson, Ruth 2022. COVID-19 vaccine response in people with multiple sclerosis. Annals of Neurology 91 (1) , pp. 89-100. 10.1002/ana.26251
file

Willis, M. D. and Robertson, N. P. 2020. Multiple sclerosis: early indicators of disease and assessing future risk. Journal of Neurology 267 (11) , pp. 3436-3438. 10.1007/s00415-020-10239-1
file

Willis, M. D. and Robertson, N. P. 2020. Multiple sclerosis and the risk of infection: considerations in the threat of the novel coronavirus, COVID-19/SARS-CoV-2. Journal of Neurology 267 (5) , pp. 1567-1569. 10.1007/s00415-020-09822-3
file

Allen, Christopher M., Feng, Jenny J., Willis, Mark D., McGinley, Marisa, Ontaneda, Daniel, Tallantyre, Emma C. and Evangelou, Nikos 2020. Clinical observation during alemtuzumab administration. Multiple Sclerosis and Related Disorders 37 , 101412. 10.1016/j.msard.2019.101412
file

Willis, M. D. and Robertson, N. P. 2019. Neurotoxicity of novel cancer immunotherapies. Journal of Neurology 266 (8) , pp. 2087-2089. 10.1007/s00415-019-09444-4
file

Willis, Mark and Robertson, Neil 2019. Technology-assisted recovery of walking after spinal cord injury. Journal of Neurology 266 (4) , pp. 1046-1048. 10.1007/s00415-019-09227-x
file

Harding, Katharine, Williams, Owain, Willis, Mark, Hrastelj, James, Rimmer, Anthony, Joseph, Fady, Tomassini, Valentina, Wardle, Mark, Pickersgill, Trevor, Robertson, Neil and Tallantyre, Emma 2019. Clinical outcomes of escalation vs early intensive disease-modifying therapy in patients with multiple sclerosis. JAMA Neurology 76 (5) , pp. 536-541. 10.1001/jamaneurol.2018.4905

Brown, J. William L., Coles, Alasdair, Horakova, Dana, Havrdova, Eva, Izquierdo, Guillermo, Prat, Alexandre, Girard, Marc, Duquette, Pierre, Trojano, Maria, Lugaresi, Alessandra, Bergamaschi, Roberto, Grammond, Pierre, Alroughani, Raed, Hupperts, Raymond, McCombe, Pamela, Van Pesch, Vincent, Sola, Patrizia, Ferraro, Diana, Grand'Maison, Francois, Terzi, Murat, Lechner-Scott, Jeannette, Flechter, Schlomo, Slee, Mark, Shaygannejad, Vahid, Pucci, Eugenio, Granella, Franco, Jokubaitis, Vilija, Willis, Mark, Rice, Claire, Scolding, Neil, Wilkins, Alastair, Pearson, Owen R, Ziemssen, Tjalf, Hutchinson, Michael, Harding, Katharine, Jones, Joanne, McGuigan, Christopher, Butzkueven, Helmut, Kalincik, Tomas and Robertson, Neil 2019. Association of initial disease-modifying therapy with later conversion to secondary progressive multiple sclerosis. Journal of the American Medical Association 321 (2) , pp. 175-187. 10.1001/jama.2018.20588

Muller, Ilaria, Willis, Mark, Healy, Sarah, Nasser, Taha, Loveless, Samantha, Butterworth, Sara, Zhang, Lei, Draman, Mohd S., Taylor, Peter N., Robertson, Neil, Dayan, Colin M. and Ludgate, Marian E. 2018. Longitudinal characterization of autoantibodies to the thyrotropin receptor (TRAb) during alemtuzumab therapy; evidence that TRAb may precede thyroid dysfunction by many years. Thyroid 28 (12) , pp. 1682-1693. 10.1089/thy.2018.0232
file

Willis, Mark D, Hope-Gill, Ben, Flood-Page, Patrick, Joseph, Fady, Needham, Ed, Jones, Joanne, Coles, Alasdair and Robertson, Neil P 2018. Sarcoidosis following alemtuzumab treatment for multiple sclerosis. Multiple Sclerosis 24 (13) , 1779-`782. 10.1177/1352458518790391
file

Harding, Katharine, Anderson, Valerie, Williams, Owain, Willis, Mark, Butterworth, Sara, Tallantyre, Emma, Joseph, Fady, Wardle, Mark, Pickersgill, Trevor and Robertson, Neil 2018. A contemporary study of mortality in the multiple sclerosis population of south east Wales. Multiple Sclerosis and Related Disorders 25 , pp. 186-191. 10.1016/j.msard.2018.08.001
file

Tallantyre, Emma Clare, Major, Paula C., Atherton, Michael J., Davies, W. Adam, Joseph, Fady, Tomassini, Valentina, Pickersgill, Trevor P., Harding, Katharine E., Willis, Mark Douglas, Winter, Mia and Robertson, Neil P. 2018. How common is truly benign MS in a UK population? Journal of Neurology, Neurosurgery and Psychiatry 90 , pp. 522-528. 10.1136/jnnp-2018-318802
file

Pariani, Nadia, Willis, Mark, Muller, Ilaria, Healy, Sarah, Nasser, Taha, McGowan, Anne, Lyons, Greta, Jones, Joanne, Chatterjee, Krishna, Dayan, Colin, Robertson, Neil, Coles, Alasdair and Moran, Carla 2018. Alemtuzumab-induced thyroid dysfunction exhibits distinctive clinical and immunological features. Journal of Clinical Endocrinology & Metabolism 108 (8) , pp. 3010-3018. 10.1210/jc.2018-00359
file

Willis, M. D. and Robertson, N. P. 2018. Myelin oligodendrocyte glycoprotein antibody-associated disease: characterising clinical disease. Journal of Neurology 265 (8) , pp. 1950-1952. 10.1007/s00415-018-8963-z
file

Alsaeed, Meshari, Harding, Katharine, Williams, O. H., Willis, Mark, Hrastelj, James, Tallantyre, Emma, Joseph, Fady, Wardle, Mark, Pickersgill, T. P. and Robertson, Neil 2018. Multiple sclerosis: long-term outcomes in ethnic minorities. analysis of a UK population-based registry. European Journal of Neurology 25 (4) , pp. 701-704. 10.1111/ene.13571
file

Ved, Ronak, Cobbold, Naomi, Igbagiri, Kueniemugh, Willis, Mark, Leach, Paul and Zaben, Malik 2017. Online patient information on Vagus Nerve Stimulation: How reliable is it for facilitating shared decision making? Seizure - European Journal of Epilepsy 50 , pp. 125-129. 10.1016/j.seizure.2017.06.009
file

Harding, Katharine, Tilling, Kate, MacIver, Claire, Willis, Mark, Joseph, Fady, Ingram, Gillian, Hirst, Claire, Wardle, Mark, Pickersgill, Trevor, Ben-Shlomo, Yoav and Robertson, Neil 2017. Seasonal variation in multiple sclerosis relapse. Journal of Neurology 264 (6) , pp. 1059-1067. 10.1007/s00415-017-8485-0
file

Willis, Mark D. and Robertson, Neil P. 2017. Chronic traumatic encephalopathy: identifying those at risk and understanding pathogenesis. Journal of Neurology 264 (6) , pp. 1298-1300. 10.1007/s00415-017-8508-x
file

Kalincik, Tomas, Brown, J. William L., Robertson, Neil, Willis, Mark, Scolding, Neil, Rice, Claire M., Wilkins, Alastair, Pearson, Owen, Ziemssen, Tjalf, Hutchinson, Michael, McGuigan, Christopher, Jokubaitis, Vilija, Spelman, Tim, Horakova, Dana, Havrdova, Eva, Trojano, Maria, Izquierdo, Guillermo, Lugaresi, Alessandra, Prat, Alexandre, Girard, Marc, Duquette, Pierre, Grammond, Pierre, Alroughani, Raed, Pucci, Eugenio, Sola, Patrizia, Hupperts, Raymond, Lechner-Scott, Jeannette, Terzi, Murat, Van Pesch, Vincent, Rozsa, Csilla, Grand'Maison, François, Boz, Cavit, Granella, Franco, Slee, Mark, Spitaleri, Daniele, Olascoaga, Javier, Bergamaschi, Roberto, Verheul, Freek, Vucic, Steve, McCombe, Pamela, Hodgkinson, Suzanne, Sanchez-Menoyo, Jose Luis, Ampapa, Radek, Simo, Magdolna, Csepany, Tunde, Ramo, Cristina, Cristiano, Edgardo, Barnett, Michael, Butzkueven, Helmut and Coles, Alasdair 2017. Treatment effectiveness of alemtuzumab compared with natalizumab, fingolimod, and interferon beta in relapsing-remitting multiple sclerosis: a cohort study. Lancet Neurology 16 (4) , pp. 271-281. 10.1016/S1474-4422(17)30007-8
file

Willis, Mark, Pearson, Owen, Illes, Zsolt, Sejbaek, Tobias, Nielson, Christian, Duddy, Martin, Petheram, Kate, van Munster, Casper, Killestein, Joep, Malmestrom, Clas, Tallantyre, Emma and Robertson, Neil 2017. An observational study of alemtuzumab following fingolimod for multiple sclerosis. Neuroimmunology and Neuroinflammation 4 (2) , E320. 10.1212/NXI.0000000000000320
file

Willis, Mark 2017. A clinical and immunological study of CD8+ T cells in multiple sclerosis. PhD Thesis, Cardiff University.
Item availability restricted.
filefile

Clement, Mathew, Pearson, James, Gras, Stephanie, Van den berg, Hugo, Lissina, Anya, Llewellyn-Lacey, Sian, Willis, Mark, Dockree, Tamsin, McLaren, James, Ekeruche-Makinde, Julia, Gostick, Emma, Robertson, Neil, Burrows, Scott, Price, David, Wong, F. Susan, Peakman, Mark, Skowera, Ania and Wooldridge, Linda 2016. Targeted suppression of autoreactive CD8+ T-cell activation using blocking anti-CD8 antibodies. Scientific Reports 6 , 35332. 10.1038/srep35332
file

Willis, Mark, Pickersgill, Trevor, Robertson, Neil, Lee, Richard W. J., Dick, Andrew D. and Carreño, Ester 2016. Alemtuzumab-induced remission of multiple sclerosis-associated uveitis. International Ophthalmology 10.1007/s10792-016-0370-9
file

Willis, Mark and Robertson, Neil 2016. Alemtuzumab for multiple sclerosis. Current Neurology and Neuroscience Reports 16 , 84. 10.1007/s11910-016-0685-y
file

Willis, Mark, Harding, Katharine, Pickersgill, T., Wardle, Mark, Pearson, O., Scolding, N., Smee, J. and Robertson, Neil 2016. Alemtuzumab for multiple sclerosis: Long term follow-up in a multi-centre cohort. Multiple Sclerosis Journal 22 (9) , pp. 1215-1223. 10.1177/1352458515614092
file

Hirst, C. L., Willis, Mark, Hussain, H. and Powell, R. 2015. Acute myeloid leucaemia presenting as a rapidly progressive polyradiculoneuropathy. BMJ Case Reports 2015 , -. 10.1136/bcr-2015-209556

Healy, Sarah, Willis, Mark and Robertson, Neil Patrick 2015. Prognosis in multiple sclerosis and the unveiling of pathogenic clues. Journal of Neurology 262 (11) , pp. 2596-2598. 10.1007/s00415-015-7938-6

Willis, Mark, Harding, Katharine, Wardle, M., Pickersgill, T. P., Tomassini, Valentina, Loveless, Samantha and Robertson, Neil 2015. Site-specific clinical disease onset in multiple sclerosis. European Journal of Neurology 22 (4) , pp. 732-735. 10.1111/ene.12564

Willis, Mark and Robertson, Neil 2015. Alemtuzumab for the treatment of multiple sclerosis. Therapeutics and Clinical Risk Management 2015 (11) , pp. 525-534. 10.2147/TCRM.S80112

Willis, M. D., Jones, L., Vincent, A., Wheeler, R., O'Callaghan, P. and Hamandi, K. 2014. VGKC-complex antibody encephalitis. QJM: An International Journal of Medicine 107 (8) , pp. 657-659. 10.1093/qjmed/hcu030

Willis, Mark and Robertson, Neil 2014. Drug safety evaluation of alemtuzumab for multiple sclerosis. Expert Opinion on Drug Safety 13 (8) , pp. 1115-1124. 10.1517/14740338.2014.928691

Willis, Mark and Robertson, Neil 2014. Treatment paradigms in multiple sclerosis: who, when and how to treat? Journal of Neurology 261 (7) , pp. 1444-1446. 10.1007/s00415-014-7420-x

Willis, Mark, Amato-Watkins, T., Zaben, M., Baig, A., Corkill, R. and Joshi, Y. 2014. Reversible brainstem dysfunction from spinal arterio-venous fistula. Practical Neurology 14 (6) , pp. 425-428. 10.1136/practneurol-2014-000872

Willis, Mark and Robertson, Neil 2013. Amyotrophic lateral sclerosis: new hope for an old disease? Journal of Neurology 260 (9) , pp. 2441-3. 10.1007/s00415-013-7063-3

Willis, Mark, Rudge, P and Walters, RJ 2013. Subacute sclerosing panencephalitis: rapidly progressive cognitive decline in a young patient. British Journal of Hospital Medicine 74 (3) , pp. 172-173. 10.12968/hmed.2013.74.3.172

Willis, Mark and Robertson, Neil 2012. Aphasia: early classification, evaluation of existing therapy, and novel therapeutics. Journal of Neurology 259 (11) , pp. 2510-2512. 10.1007/s00415-012-6701-5

This list was generated on Wed Aug 17 23:10:37 2022 BST.


Maintained by Cardiff University Information Services